Tecan to present at Jefferies 2016 London Healthcare Conference
09 Noviembre 2016 - 3:00AM
Tecan Group AG / Tecan to present at Jefferies 2016 London
Healthcare Conference . Processed and transmitted by Nasdaq
Corporate Solutions. The issuer is solely responsible for the
content of this announcement.
Männedorf, Switzerland, November 9, 2016 - The Tecan
Group (SIX Swiss Exchange: TECN) today announced that it will
present at the Jefferies 2016 London Healthcare Conference on
November 16, 2016.
The investor
presentation by David Martyr, CEO of Tecan, will begin at 10:40 am
GMT (11:40 am CET) and will be webcast live. The webcast may be
accessed under the "Investor Relations" tab of Tecan's website
www.tecan.com.
A replay of the webcast
will be available after the presentation and will remain available
for 90 days.
About
Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions in biopharmaceuticals, forensics and
clinical diagnostics. The company specializes in the development,
production and distribution of automated workflow solutions for
laboratories in the life sciences sector. Its clients include
pharmaceutical and biotechnology companies, university research
departments, and forensic and diagnostic laboratories. As an
original equipment manufacturer (OEM), Tecan is also a leader in
developing and manufacturing OEM instruments and components that
are then distributed by partner companies. Founded in Switzerland
in 1980, the company has manufacturing, research and development
sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2015, Tecan generated sales of
CHF 440 million (USD 459 million;
EUR 411 million). Registered shares of Tecan Group are
traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For
further information:
Tecan
Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Press Release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Tecan Group AG via Globenewswire
--- End of Message ---
Tecan Group AG
Seestrasse 103 Maennedorf Switzerland
ISIN: CH0012100191;